Unicycive Therapeutics Inc (UNCY) earnings · $195.0M cap
These earnings events as JSON? API free 100/dayUnicycive Therapeutics Inc (UNCY) is a biotechnology company listed on NASDAQ.
This UNCY earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported UNCY revenue for 2023-09-30 was $675.0K. Net income was -$4.3M. Revenue was up 0.0% from 2023-06-30 to 2023-09-30. UNCY currently screens at market cap $195.0M.
When the next UNCY 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 0.0% from 2023-06-30 to 2023-09-30. An earnings headline that ignores that move is noise.
Not investment advice. Full UNCY research stays on the stock page; the tape stays on the quote page.
UNCY earnings FAQ
What are UNCY's latest revenue and net income?
Latest cached Unicycive Therapeutics Inc (UNCY) revenue for Sep 30, 2023 was $675.0K. Net income was -$4.3M. Statements: https://lician.com/financials/uncy
What period does the latest UNCY earnings print cover?
The latest cached Unicycive Therapeutics Inc (UNCY) earnings print covers Sep 30, 2023. The prior cached period on this page is Jun 30, 2023.
How did UNCY revenue change from the prior cached period?
Cached Unicycive Therapeutics Inc (UNCY) revenue was unchanged from $675.0K (Jun 30, 2023) to $675.0K (Sep 30, 2023). Statements: https://lician.com/financials/uncy
Where are UNCY earnings listed?
Cached earnings facts for Unicycive Therapeutics Inc (UNCY) are listed at https://lician.com/earnings/uncy. Statements: https://lician.com/financials/uncy
Not investment advice.